Dr Dongbin Jin is a member of the Translational Antigen Discovery Research group in the Centre for Cancer Research.
Areas of interest
Dr Dongbin Jin is a Postdoctoral Research Fellow in the Translational Antigen Discovery research group.
Dr Jin undertook a Bachelor of Science in Biology major in China, and Master of Science in Cellular Immunology major in South Korea. He then did his PhD and postdoctoral research at the Garvan Institute in Sydney, under the supervision of Prof Jonathan Sprent. At Garvan, Dr Jin used preclinical models to develop novel vaccine technologies that can massively expand tumour killing T cells.
Dr Jin joined Dr Pouya Faridi’s laboratory in 2022 to develop highly effective cancer vaccines by combining his vaccine technologies with Dr Faridi’s novel cancer antigen discovery technologies.